Comparative in vitro and in vivo activity of rifabutin and rifampicin against mycobacterium avium complex
- 1 September 1988
- Vol. 69 (3) , 187-192
- https://doi.org/10.1016/0041-3879(88)90020-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Two Groups ofMycobacterium aviumComplex Strains Determined According to the Susceptibility to Rifampicin and AnsamycinMicrobiology and Immunology, 1987
- Mycobacterium avium-complex infections in normal and immunodeficient miceTubercle, 1987
- Rifabutin (Ansamycin LM 427): A New Rifamycin-S Derivative for the Treatment of Mycobacterial DiseasesClinical Infectious Diseases, 1987
- Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsAntimicrobial Agents and Chemotherapy, 1985
- An Acute Infection Model forMycobacterium intracellulareDisease Using Beige Mice: Preliminary Results1,2American Review of Respiratory Disease, 1983
- LM 427,a new spiropiperidylrifamycin: In vitro and in vivo studies.The Journal of Antibiotics, 1983
- Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins.The Journal of Antibiotics, 1980